Retatutide
$40.00
Retatrutide is an investigational, once-weekly injectable medication developed by Eli Lilly for chronic weight management and type 2 diabetes. Unlike older single or dual medications, it is a "triple-agonist" that simultaneously activates three distinct metabolic hormone receptors: GLP-1, GIP, and glucagon.